| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0.003 | 0.989 | Analgesic | 0.989 0.003 CID_4639 0.983 0.003 CID_627285 | CID_4639 | |
| 0.956 | 0.001 | 0.984 | Analgesic, opioid | 0.984 0.001 CID_4639 0.961 0.001 CID_627285 | CID_4639 | |
| 0.936 | 0.001 | 0.985 | Opioid antagonist | 0.985 0.001 CID_4639 0.891 0.001 CID_627285 | CID_4639 | |
| 0.934 | 0.001 | 0.988 | Opioid mu receptor antagonist | 0.988 0.001 CID_4639 0.87 0.001 CID_627285 | CID_4639 | |
| 0.932 | 0.001 | 0.954 | Opioid agonist | 0.954 0.001 CID_4639 0.933 0.001 CID_627285 | CID_4639 | |
| 0.907 | 0.001 | 0.931 | Opioid mu receptor agonist | 0.931 0.001 CID_4639 0.891 0.001 CID_627285 | CID_4639 | |
| 0.902 | 0.001 | 0.972 | Opioid delta receptor antagonist | 0.972 0.001 CID_4639 0.843 0.001 CID_627285 | CID_4639 | |
| 0.874 | 0.001 | 0.958 | Opioid kappa receptor antagonist | 0.958 0.001 CID_4639 0.807 0.001 CID_627285 | CID_4639 | |
| 0.862 | 0.001 | 0.93 | Opioid delta receptor agonist | 0.93 0.001 CID_4639 0.895 0.001 CID_627285 | CID_4639 | |
| 0.812 | 0.002 | 0.843 | Antipruritic | 0.843 0.002 CID_4639 0.707 0.003 CID_627285 | CID_4639 | |
| 0.788 | 0.003 | 0.839 | Sigma receptor antagonist | 0.839 0.003 CID_4639 0.67 0.004 CID_627285 | CID_4639 | |
| 0.774 | 0.004 | 0.777 | Psychostimulant | 0.777 0.004 CID_4639 0.685 0.004 CID_627285 | CID_4639 | |
| 0.757 | 0.001 | 0.814 | Opioid kappa receptor agonist | 0.814 0.001 CID_4639 0.666 0.001 CID_627285 | CID_4639 | |
| 0.725 | 0.002 | 0.752 | Toll-Like receptor antagonist | 0.752 0.002 CID_4639 0.54 0.003 CID_627285 | CID_4639 | |
| 0.681 | 0.023 | 0.681 | Transcription factor NF kappa B inhibitor | 0.679 0.023 CID_4639 0.617 0.029 CID_627285 | ||
| 0.62 | 0.001 | 0.666 | Toll-Like receptor 4 antagonist | 0.666 0.001 CID_4639 0.581 0.001 CID_627285 | CID_4639 | |
| 0.576 | 0.005 | 0.598 | Anesthetic general | 0.598 0.005 CID_4639 0.491 0.008 CID_627285 | CID_4639 | |
| 0.527 | 0.02 | 0.556 | Spasmolytic | 0.556 0.017 CID_4639 0.33 0.059 CID_627285 | CID_4639 | |
| 0.468 | 0.004 | 0.597 | Acetylcholine M1 receptor antagonist | 0.597 0.003 CID_4639 0.276 0.019 CID_627285 | CID_4639 | |
| 0.475 | 0.012 | 0.475 | Sigma receptor agonist | 0.467 0.013 CID_4639 0.161 0.078 CID_627285 | ||
| 0.441 | 0.005 | 0.488 | Breast cancer-resistant protein inhibitor | 0.373 0.005 CID_4639 0.488 0.005 CID_627285 | CID_627285 | |
| 0.433 | 0.004 | 0.442 | Cyclooxygenase 3 inhibitor | 0.343 0.005 CID_4639 0.442 0.004 CID_627285 | CID_627285 | |
| 0.416 | 0.014 | 0.416 | P-glycoprotein inhibitor | 0.347 0.021 CID_4639 0.332 0.024 CID_627285 | ||
| 0.417 | 0.042 | 0.427 | 5 Hydroxytryptamine release stimulant | 0.427 0.041 CID_4639 0.313 0.066 CID_627285 | CID_4639 | |
| 0.337 | 0.008 | 0.37 | Toll-Like receptor 9 antagonist | 0.37 0.005 CID_4639 0.24 0.023 CID_627285 | CID_4639 | |
| 0.365 | 0.068 | 0.365 | Vasodilator, peripheral | 0.26 0.12 CID_4639 | ||
| 0.314 | 0.017 | 0.392 | Cholinergic | 0.282 0.022 CID_4639 0.392 0.01 CID_627285 | CID_627285 | |
| 0.367 | 0.078 | 0.544 | Immunosuppressant | 0.394 0.066 CID_4639 0.544 0.022 CID_627285 | CID_627285 | |
| 0.319 | 0.037 | 0.323 | Nitric oxide antagonist | 0.323 0.036 CID_4639 0.298 0.041 CID_627285 | CID_4639 | |
| 0.282 | 0.016 | 0.341 | Cholinergic antagonist | 0.341 0.011 CID_4639 0.16 0.047 CID_627285 | CID_4639 | |
| 0.278 | 0.016 | 0.321 | Acetylcholinesterase inhibitor | 0.245 0.022 CID_4639 0.321 0.011 CID_627285 | CID_627285 | |
| 0.275 | 0.016 | 0.334 | Acetylcholine antagonist | 0.334 0.011 CID_4639 0.156 0.047 CID_627285 | CID_4639 | |
| 0.296 | 0.047 | 0.323 | 5 Hydroxytryptamine uptake stimulant | 0.27 0.064 CID_4639 0.323 0.035 CID_627285 | CID_627285 | |
| 0.258 | 0.013 | 0.316 | Acetylcholine muscarinic antagonist | 0.316 0.008 CID_4639 0.13 0.058 CID_627285 | CID_4639 | |
| 0.259 | 0.024 | 0.259 | Protein kinase stimulant | 0.259 0.024 CID_4639 0.198 0.042 CID_627285 | ||
| 0.298 | 0.067 | 0.298 | Hypoxia-inducible factor 1 alpha inhibitor | 0.292 0.069 CID_4639 0.18 0.179 CID_627285 | ||
| 0.218 | 0.009 | 0.222 | Antineoplastic alkaloid | 0.222 0.009 CID_4639 0.209 0.011 CID_627285 | CID_4639 | |
| 0.288 | 0.085 | 0.288 | Caspase 3 stimulant | 0.259 0.105 CID_4639 0.237 0.124 CID_627285 | ||
| 0.238 | 0.047 | 0.238 | Hepatoprotectant | 0.23 0.05 CID_4639 0.206 0.061 CID_627285 | ||
| 0.171 | 0.004 | 0.232 | Nociceptin (N/OFQ) receptor antagonist | 0.232 0.004 CID_4639 0.122 0.005 CID_627285 | CID_4639 | |
| 0.188 | 0.065 | 0.192 | Lipocortins synthesis antagonist | 0.192 0.061 CID_4639 0.176 0.074 CID_627285 | CID_4639 | |
| 0.209 | 0.12 | 0.241 | Tyrosine 3 hydroxylase inhibitor | 0.241 0.077 CID_4639 0.225 0.097 CID_627285 | CID_4639 | |
| 0.093 | 0.005 | 0.098 | Prolactin release inhibitor | 0.098 0.005 CID_4639 0.074 0.017 CID_627285 | CID_4639 | |
| 0.125 | 0.041 | 0.125 | Electron transport complex I inhibitor | 0.112 0.058 CID_4639 0.115 0.054 CID_627285 | ||
| 0.198 | 0.115 | 0.245 | Antioxidant | 0.245 0.087 CID_4639 0.197 0.116 CID_627285 | CID_4639 | |
| 0.084 | 0.004 | 0.114 | Nociceptin (N/OFQ) receptor agonist | 0.114 0.004 CID_4639 0.065 0.005 CID_627285 | CID_4639 | |
| 0.286 | 0.209 | 0.286 | Caspase 9 stimulant | 0.275 0.223 CID_627285 | ||
| 0.116 | 0.054 | 0.116 | Expectorant | 0.101 0.068 CID_627285 | ||
| 0.091 | 0.035 | 0.125 | CC chemokine 5 receptor agonist | 0.125 0.007 CID_4639 0.081 0.062 CID_627285 | CID_4639 | |
| 0.107 | 0.052 | 0.115 | Estrogen receptor beta antagonist | 0.115 0.038 CID_4639 0.106 0.053 CID_627285 | CID_4639 | |
| 0.084 | 0.029 | 0.084 | Orexin receptor 1 antagonist | |||
| 0.104 | 0.051 | 0.136 | Prolactin inhibitor | 0.136 0.028 CID_4639 0.086 0.072 CID_627285 | CID_4639 | |
| 0.113 | 0.069 | 0.122 | Estrogen antagonist | 0.122 0.051 CID_4639 0.117 0.061 CID_627285 | CID_4639 | |
| 0.077 | 0.039 | 0.099 | Dopamine agonist | 0.099 0.028 CID_4639 | CID_4639 | |
| 0.057 | 0.021 | 0.071 | Dopamine D5 antagonist | 0.071 0.015 CID_4639 | CID_4639 | |
| 0.139 | 0.107 | 0.143 | Interleukin 6 antagonist | 0.143 0.1 CID_4639 | CID_4639 | |
| 0.098 | 0.068 | 0.098 | Alpha 2c adrenoreceptor antagonist | |||
| 0.088 | 0.058 | 0.088 | Alpha 2 adrenoreceptor antagonist | 0.08 0.066 CID_4639 | ||
| 0.13 | 0.107 | 0.145 | Growth hormone agonist | 0.145 0.091 CID_4639 0.133 0.103 CID_627285 | CID_4639 | |
| 0.049 | 0.027 | 0.067 | Dopamine D2 agonist | 0.067 0.018 CID_4639 | CID_4639 | |
| 0.244 | 0.222 | 0.244 | Apoptosis agonist | |||
| 0.132 | 0.111 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 CID_4639 | CID_4639 | |
| 0.066 | 0.047 | 0.066 | Orexin receptor antagonist | |||
| 0.023 | 0.015 | 0.032 | Dopamine D1 agonist | 0.032 0.008 CID_4639 0.024 0.014 CID_627285 | CID_4639 | |
| 0.05 | 0.045 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | 0.051 0.042 CID_4639 | CID_4639 | |
| 0.068 | 0.067 | 0.073 | Antineoplastic antibiotic | 0.073 0.063 CID_4639 0.071 0.064 CID_627285 | CID_4639 | |
| 0.07 | 0.069 | 0.074 | Acetylcholine nicotinic antagonist | 0.074 0.063 CID_4639 | CID_4639 | |
| 0.124 | 0.126 | 0.152 | Melanin inhibitor | 0.138 0.1 CID_4639 0.152 0.079 CID_627285 | CID_627285 | |
| 0.022 | 0.032 | 0.033 | Estrogen receptor alpha agonist | 0.033 0.024 CID_4639 | CID_4639 | |
| 0.061 | 0.072 | 0.074 | Alpha 2a adrenoreceptor antagonist | 0.074 0.053 CID_4639 | CID_4639 | |
| 0.035 | 0.048 | 0.052 | Estrogen agonist | 0.052 0.034 CID_4639 | CID_4639 | |
| 0.017 | 0.031 | 0.051 | Estrogen receptor beta agonist | 0.051 0.019 CID_4639 | CID_4639 | |
| 0.049 | 0.067 | 0.069 | Dopamine D1 antagonist | 0.069 0.04 CID_4639 | CID_4639 | |
| 0.175 | 0.194 | 0.196 | Immunomodulator | 0.196 0.169 CID_4639 | CID_4639 | |
| 0.138 | 0.162 | 0.187 | Free radical scavenger | 0.187 0.109 CID_4639 | CID_4639 | |
| 0.109 | 0.138 | 0.129 | NOS3 expression enhancer | 0.129 0.1 CID_4639 | CID_4639 | |
| 0.077 | 0.116 | 0.087 | Alpha 2d adrenoreceptor antagonist | 0.087 0.078 CID_627285 | CID_627285 | |
| 0.045 | 0.096 | 0.071 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 CID_4639 0.071 0.059 CID_627285 | CID_627285 | |
| 0.184 | 0.24 | 0.206 | Calcium channel activator | 0.206 0.204 CID_627285 | CID_627285 | |
| 0.064 | 0.122 | 0.124 | Creatine kinase inhibitor | 0.124 0.038 CID_4639 | CID_4639 | |
| 0.067 | 0.181 | 0.11 | Lipid peroxidase inhibitor | 0.11 0.105 CID_4639 | CID_4639 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |